Nalaganje...
SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
INTRODUCTION Teriparatide is a recombinant endogenous parathyroid hormone. It is an anabolic medication which is FDA approved for treating Osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis and Glucocorticoid-induced osteoporosis. Transient hypercalcemia with Teripara...
Shranjeno v:
| izdano v: | J Endocr Soc |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Endocrine Society
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552103/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-505 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|